Concepedia

Author

François Bayle

Hospices Civils de Lyon

Also Known As

F Bayle, F. Bayle, Francois Bayle, François Bayle, François Bayle, N Pernin, Sabine Bayen

106

Publications

1.5K

Citations

20

H-Index

70

Concepts

All Affiliations

Hospices Civils de LyonInsermCentre Hospitalier Universitaire de GrenobleCentre Hospitalier Universitaire de BesançonUniversity Hospital of Geneva
FB

About

François Bayle is an author at Hospices Civils de Lyon specializing in medicine, pancreas transplantation, and islet transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

360

2

Health Sciences

3

3

64

3

Arts

2

2

33

4

Language Studies

2

2

38

5

Engineering

1

1

13

François Bayle

×

29

Publications

1.4K

Citations

20

H-Index

YearCitations

Kidney and Recipient Weight Incompatibility Reduces Long-Term Graft Survival

Magali Giral, Yohann Foucher, Georges Karam,

Journal of the American Society of Nephrology

2010

124

Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network

Sandrine Lablanche, Sophie Borot, Anne Wojtusciszyn,

Diabetes Care

2015

117

Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000)

Christian Toso, Laurence Kessler, Alfred Penfornis,

Diabetologia

2001

115

Incidence of Delayed Graft Function and Wound Healing Complications After Deceased-Donor Kidney Transplantation Is not Affected by De Novo Everolimus

Laetitia Albano, F. Berthoux, Marie‐Christine Moal,

Transplantation

2009

81

A clinical scoring system highly predictive of long-term kidney graft survival

Yohann Foucher, Pascal Daguin, Ahmed Akl,

Kidney International

2010

80

Expectations and Strategies Regarding Islet Transplantation: Metabolic Data From the GRAGIL 2 Trial

Lionel Badet, Pierre‐Yves Benhamou, Anne Wojtusciszyn,

Transplantation

2007

78

Efficacy and safety of de novo or early everolimus with low cyclosporine in deceased-donor kidney transplant recipients at specified risk of delayed graft function: 12-month results of a randomized, multicenter trial

Jacques Dantal, F. Berthoux, Marie‐Christine Moal,

Transplant International

2010

71

Cost Analysis of Human Islet Transplantation for the Treatment of Type 1 Diabetes in the Swiss-French Consortium GRAGIL

Adrienne Guignard, José Oberholzer, Pierre‐Yves Benhamou,

Diabetes Care

2004

68

Quality of life after islet transplantation: data from the GRAGIL 1 and 2 trials

Pierre‐Yves Benhamou, Laure Guittard, Anne Wojtusciszyn,

Diabetic Medicine

2009

66

Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study

Rachel Hellemans, Marc Hazzan, D. Durand,

American Journal of Transplantation

2015

55

Page 1